Human chemokine HCC-1 polypeptides to improve stem cell transplantation

Details for Australian Patent Application No. 2004283853 (hide)

Owner TAP Pharmaceutical Products Inc.

Inventors Forssmann, Wolf-Georg; Richter, Rudolf; Henschler, Reinhard

Agent Davies Collison Cave

Pub. Number AU-A-2004283853

PCT Pub. Number WO2005/040209

Priority 04003716.0 19.02.04 EP; 10349966.0 24.10.03 DE

Filing date 16 October 2004

Wipo publication date 6 May 2005

International Classifications

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040209 Priority application(s): WO2005/040209

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283854-Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors

2004283850-Multispecific deimmunized CD3-binders